Angelor
Venture capitalPre-Seed–Series A
Find your way into Angelor
Investment thesis
Angelor invests in French healthcare innovations, supporting companies from early spin-off stage through Series A once they have demonstrated medical and economic potential. It provides not only capital but also business and health-sector expertise, acting as a sparring partner to entrepreneurs with the help of an active community of experienced investors and mentors. The firm aims to accelerate the clinical, industrial and commercial scaling of innovations capable of improving patient health within five years, pursuing a dual goal of economic performance and medical progress. A portion of its carried interest is donated to health-focused associations.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 2 of 2 portfolio companiesClimate Tech ×2FoodTech ×2AgTech ×1Biotech ×1
HQs:France×2
Investments · 2 tracked
founders shown can be your intro path
nextProtein breeds Black Soldier Fly larvae on unconsumed food to produce insect-based protein, oil and fertilizer used as ingredients in animal feed for aquaculture, poultry, pork and pet food.
AgTechClimate TechFoodTechParis, FR
Syrine Chaalala(Co-founder)inMohamed Gastli(Co-founder)in
Co-investorsKima VenturesAnaxagoBritish International InvestmentMirovaRAISE
Standing Ovation is a French protein company that uses precision fermentation to produce non-animal proteins such as casein (its patented Advanced Casein) and Tertia Protein, a single-cell protein for animal nutrition.
BiotechClimate TechFoodTech
Co-investorsAstanor VenturesBig Idea VenturesBpifrancePeakBridge VCSeventure Partners
Portfolio news
latest coverage across their companiesStanding Ovation · worldbiomarketinsights.com · Apr 20, 2026
nextProtein · feedandadditive.com · Nov 7, 2025
Frequently asked questions
- What stage does Angelor invest at?
- Angelor invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Angelor focus on?
- Angelor focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.